Cargando…
The Gatekeeper™ for fecal incontinence: Another trial and error
INTRODUCTION: The Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incontinence with no reported complications. This case reports side effects similar to other bulking agents, namely migration of the prosthesis and perianal abscess. PRESENTATION OF CASE: A 52 year old gent...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275818/ https://www.ncbi.nlm.nih.gov/pubmed/25460440 http://dx.doi.org/10.1016/j.ijscr.2014.08.002 |
_version_ | 1782350182606700544 |
---|---|
author | Al-Ozaibi, Labib Kazim, Yasmin Hazim, Wessam Al-Mazroui, Alya Al-Badri, Faisal |
author_facet | Al-Ozaibi, Labib Kazim, Yasmin Hazim, Wessam Al-Mazroui, Alya Al-Badri, Faisal |
author_sort | Al-Ozaibi, Labib |
collection | PubMed |
description | INTRODUCTION: The Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incontinence with no reported complications. This case reports side effects similar to other bulking agents, namely migration of the prosthesis and perianal abscess. PRESENTATION OF CASE: A 52 year old gentleman presented with a history of fecal soiling. He underwent uncomplicated surgery in 2012 for 6 Gatekeeper™ implantations with only temporary improvements. In 2013, endorectal ultrasound revealed prosthesis migration. In 2014, he presented with a perianal abscess which contained one of the prosthesis. DISCUSSION: The Gatekeeper™, made of the inert Hyexpan, typically implanted in the intersphincteric region, has been used for the treatment of fecal incontinence since its discontinuation in the treatment of gastroesophageal reflux disease.(5) The Gatekeeper™ was implemented on a small number of subjects for which the typical side effects of bulking agents were not seen. CONCLUSION: Larger studies need to be conducted to investigate the advantages or perhaps disadvantages of the Gatekeeper™ over other bulking agents. |
format | Online Article Text |
id | pubmed-4275818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-42758182014-12-28 The Gatekeeper™ for fecal incontinence: Another trial and error Al-Ozaibi, Labib Kazim, Yasmin Hazim, Wessam Al-Mazroui, Alya Al-Badri, Faisal Int J Surg Case Rep Article INTRODUCTION: The Gatekeeper™ is the most recent bulking agent used in the treatment of fecal incontinence with no reported complications. This case reports side effects similar to other bulking agents, namely migration of the prosthesis and perianal abscess. PRESENTATION OF CASE: A 52 year old gentleman presented with a history of fecal soiling. He underwent uncomplicated surgery in 2012 for 6 Gatekeeper™ implantations with only temporary improvements. In 2013, endorectal ultrasound revealed prosthesis migration. In 2014, he presented with a perianal abscess which contained one of the prosthesis. DISCUSSION: The Gatekeeper™, made of the inert Hyexpan, typically implanted in the intersphincteric region, has been used for the treatment of fecal incontinence since its discontinuation in the treatment of gastroesophageal reflux disease.(5) The Gatekeeper™ was implemented on a small number of subjects for which the typical side effects of bulking agents were not seen. CONCLUSION: Larger studies need to be conducted to investigate the advantages or perhaps disadvantages of the Gatekeeper™ over other bulking agents. Elsevier 2014-10-12 /pmc/articles/PMC4275818/ /pubmed/25460440 http://dx.doi.org/10.1016/j.ijscr.2014.08.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Article Al-Ozaibi, Labib Kazim, Yasmin Hazim, Wessam Al-Mazroui, Alya Al-Badri, Faisal The Gatekeeper™ for fecal incontinence: Another trial and error |
title | The Gatekeeper™ for fecal incontinence: Another trial and error |
title_full | The Gatekeeper™ for fecal incontinence: Another trial and error |
title_fullStr | The Gatekeeper™ for fecal incontinence: Another trial and error |
title_full_unstemmed | The Gatekeeper™ for fecal incontinence: Another trial and error |
title_short | The Gatekeeper™ for fecal incontinence: Another trial and error |
title_sort | gatekeeper™ for fecal incontinence: another trial and error |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275818/ https://www.ncbi.nlm.nih.gov/pubmed/25460440 http://dx.doi.org/10.1016/j.ijscr.2014.08.002 |
work_keys_str_mv | AT alozaibilabib thegatekeeperforfecalincontinenceanothertrialanderror AT kazimyasmin thegatekeeperforfecalincontinenceanothertrialanderror AT hazimwessam thegatekeeperforfecalincontinenceanothertrialanderror AT almazrouialya thegatekeeperforfecalincontinenceanothertrialanderror AT albadrifaisal thegatekeeperforfecalincontinenceanothertrialanderror AT alozaibilabib gatekeeperforfecalincontinenceanothertrialanderror AT kazimyasmin gatekeeperforfecalincontinenceanothertrialanderror AT hazimwessam gatekeeperforfecalincontinenceanothertrialanderror AT almazrouialya gatekeeperforfecalincontinenceanothertrialanderror AT albadrifaisal gatekeeperforfecalincontinenceanothertrialanderror |